SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-006143
Filing Date
2022-04-26
Accepted
2022-04-26 08:37:14
Documents
52
Period of Report
2022-04-26
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K cyt-20220426.htm   iXBRL 8-K 55689
2 EX-99.1 cyt-ex99_1.htm EX-99.1 32702
3 GRAPHIC cyt-ex99_1s1.jpg GRAPHIC 31092
4 GRAPHIC cyt-ex99_1s2.jpg GRAPHIC 136511
5 GRAPHIC cyt-ex99_1s3.jpg GRAPHIC 49857
6 GRAPHIC cyt-ex99_1s4.jpg GRAPHIC 85107
7 GRAPHIC cyt-ex99_1s5.jpg GRAPHIC 70694
8 GRAPHIC cyt-ex99_1s6.jpg GRAPHIC 61289
9 GRAPHIC cyt-ex99_1s7.jpg GRAPHIC 33736
10 GRAPHIC cyt-ex99_1s8.jpg GRAPHIC 80026
11 GRAPHIC cyt-ex99_1s9.jpg GRAPHIC 78546
12 GRAPHIC cyt-ex99_1s10.jpg GRAPHIC 53927
13 GRAPHIC cyt-ex99_1s11.jpg GRAPHIC 50703
14 GRAPHIC cyt-ex99_1s12.jpg GRAPHIC 89308
15 GRAPHIC cyt-ex99_1s13.jpg GRAPHIC 53758
16 GRAPHIC cyt-ex99_1s14.jpg GRAPHIC 51304
17 GRAPHIC cyt-ex99_1s15.jpg GRAPHIC 52382
18 GRAPHIC cyt-ex99_1s16.jpg GRAPHIC 79522
19 GRAPHIC cyt-ex99_1s17.jpg GRAPHIC 56583
20 GRAPHIC cyt-ex99_1s18.jpg GRAPHIC 39289
21 GRAPHIC cyt-ex99_1s19.jpg GRAPHIC 91229
22 GRAPHIC cyt-ex99_1s20.jpg GRAPHIC 76451
23 GRAPHIC cyt-ex99_1s21.jpg GRAPHIC 70715
24 GRAPHIC cyt-ex99_1s22.jpg GRAPHIC 57045
25 GRAPHIC cyt-ex99_1s23.jpg GRAPHIC 33822
26 GRAPHIC cyt-ex99_1s24.jpg GRAPHIC 77481
27 GRAPHIC cyt-ex99_1s25.jpg GRAPHIC 79038
28 GRAPHIC cyt-ex99_1s26.jpg GRAPHIC 35892
29 GRAPHIC cyt-ex99_1s27.jpg GRAPHIC 65258
30 GRAPHIC cyt-ex99_1s28.jpg GRAPHIC 59480
31 GRAPHIC cyt-ex99_1s29.jpg GRAPHIC 69108
32 GRAPHIC cyt-ex99_1s30.jpg GRAPHIC 52306
33 GRAPHIC cyt-ex99_1s31.jpg GRAPHIC 85851
34 GRAPHIC cyt-ex99_1s32.jpg GRAPHIC 74784
35 GRAPHIC cyt-ex99_1s33.jpg GRAPHIC 64868
36 GRAPHIC cyt-ex99_1s34.jpg GRAPHIC 82734
37 GRAPHIC cyt-ex99_1s35.jpg GRAPHIC 19760
38 GRAPHIC cyt-ex99_1s36.jpg GRAPHIC 52790
39 GRAPHIC cyt-ex99_1s37.jpg GRAPHIC 59595
40 GRAPHIC cyt-ex99_1s38.jpg GRAPHIC 87120
41 GRAPHIC cyt-ex99_1s39.jpg GRAPHIC 30583
  Complete submission text file 0000950170-22-006143.txt   3641761

Data Files

Seq Description Document Type Size
42 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cyt-20220426_pre.xml EX-101.PRE 11454
43 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cyt-20220426.xsd EX-101.SCH 2469
44 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cyt-20220426_lab.xml EX-101.LAB 13987
46 EXTRACTED XBRL INSTANCE DOCUMENT cyt-20220426_htm.xml XML 4895
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40499 | Film No.: 22851890
SIC: 2834 Pharmaceutical Preparations